In today’s recent session, 4.17 million shares of the Akoya Biosciences Inc (NASDAQ:AKYA) have been traded, and its beta is 1.22. Most recently the company’s share price was $2.14, and it changed around -$0.1 or -4.43% from the last close, which brings the market valuation of the company to $106.10M. AKYA at last check was trading at a discount to its 52-week high of $6.31, offering almost -194.86% off that amount. The share price’s 52-week low was $1.88, which indicates that the recent value has risen by an impressive 12.15% since then. We note from Akoya Biosciences Inc’s average daily trading volume that its 10-day average is 97070.0 shares, with the 3-month average coming to 152.35K.
Akoya Biosciences Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 5 recommended AKYA as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Akoya Biosciences Inc (NASDAQ:AKYA) trade information
Instantly AKYA has been showing red trend so far today with a performance of -4.43% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.52 on recent trading dayincreased the stock’s daily price by 15.08%. The company’s shares are currently down -56.13% year-to-date, but still down -2.25% over the last five days. On the other hand, Akoya Biosciences Inc (NASDAQ:AKYA) is -32.47% down in the 30-day period. We can see from the shorts that 1.6 million shares have been sold at a short interest cover period of 13.43 day(s).
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to increase their stock price by 46.5% from its current value. Analyst projections state that AKYA is forecast to be at a low of $3 and a high of $7.5.
Akoya Biosciences Inc (AKYA) estimates and forecasts
Akoya Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -2.25 percent over the past six months and at a 22.38% annual growth rate that is well above the industry average of 17.10%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -37.60%.
AKYA Dividends
Akoya Biosciences Inc’s next quarterly earnings report is expected to be released in January.
Akoya Biosciences Inc (NASDAQ:AKYA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.09% of Akoya Biosciences Inc shares, and 70.19% of them are in the hands of institutional investors. The stock currently has a share float of 78.94%. Akoya Biosciences Inc stock is held by 93.0 institutions, with BLUE WATER LIFE SCIENCE ADVISORS, LP being the largest institutional investor. By 2024-06-30, it held 9.5506% of the shares, which is about 4.7 million shares worth $10.99 million.
BLACKROCK INC., with 3.0534% or 1.5 million shares worth $3.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
